Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > IBC Life Sciences Presents the 19th Annual International Antibody Engineering Conference

Abstract:
IBC Life Sciences announces the 19th Annual International Antibody Engineering Conference will return to San Diego, California on December 7-11, 2008. This meeting serves as the annual forum of the antibody and protein engineering communities, providing insights to drive the future of antibody engineering and the development of immunotherapeutics.

IBC Life Sciences Presents the 19th Annual International Antibody Engineering Conference

San Diego, CA | Posted on October 11th, 2008

This year's Keynote speakers have been leading pioneers in this field since its beginning, having contributed many of the advancements that engendered the current revolution in recombinant antibodies and their successful clinical application, making antibody therapy a major new area of modern medicine. Dr. Michael L. Neuberger, Ph.D., from the MRC Laboratory of Molecular Biology, will discuss the evolving technologies of antibody engineering, and Professor Sherie Morrison, Ph.D., from UCLA, will discuss the versatility of antibodies for multiple applications.

In addition, an international speaker faculty will discuss their latest, far-reaching investigations on microarrays and nanotechnology for antibody discovery and analysis; the theory, practice and use of libraries based on restricted amino acid sets; non-antibody scaffolds; intrabodies; novel antibody targets and applications; target selection in relation to efficacy; and a revisiting of the mechanism of antibody action.

The meeting expects more than 700 attendees and is co-located with IBC's 6th Annual International Antibody Therapeutics Conference being held on December 9-11, 2008.

The Scientific Sponsor of the meeting is The Antibody Society, which is dedicated to furthering the interests of antibody engineering, therapeutic development and the safe and thorough testing of future therapeutic agents.

Complete details on this meeting can be found at http://www.ibclifesciences.com/antibodyeng, and to receive a press pass or arrange an interview with a speaker, email Dawn O'Connor at .

####

About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value.

For more information, please click here

Copyright © IBC Life Sciences

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Imaging individual flexible DNA 'building blocks' in 3-D: Berkeley Lab researchers generate first images of 129 DNA structures February 22nd, 2018

'Memtransistor' brings world closer to brain-like computing: Combined memristor and transistor can process information and store memory with one device February 22nd, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease February 22nd, 2018

MEMS chips get metatlenses: Combining metasurface lenses with MEMS technology could add high-speed scanning and enhance focusing capability of optical systems February 21st, 2018

Nanomedicine

Imaging individual flexible DNA 'building blocks' in 3-D: Berkeley Lab researchers generate first images of 129 DNA structures February 22nd, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease February 22nd, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

Announcements

Imaging individual flexible DNA 'building blocks' in 3-D: Berkeley Lab researchers generate first images of 129 DNA structures February 22nd, 2018

'Memtransistor' brings world closer to brain-like computing: Combined memristor and transistor can process information and store memory with one device February 22nd, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease February 22nd, 2018

MEMS chips get metatlenses: Combining metasurface lenses with MEMS technology could add high-speed scanning and enhance focusing capability of optical systems February 21st, 2018

Events/Classes

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Leti’s Chief Scientist Presents Optimistic Vision for Neuromorphic Hardware and Ultra-Low-Power Microdevices for Edge Computing at ISSCC: Leti’s Chief Scientist Presents Optimistic Vision for Neuromorphic Hardware and Ultra-Low-Power Microdevices That Are Based on Novel Emerging February 13th, 2018

Leti Chief Scientist Barbara De Salvo Will Help Kick Off ISSCC 2018 with Opening-Day Keynote: In Addition, Leti Scientists Will Present and Demo New Technology for Piezoelectric Energy Harvesting February 8th, 2018

Leti Presents Optical-Equipment Curving Technology that Improves Performance, Cuts Costs: ‘Disruptive Approach’ for Imaging Applications Presented in Paper At Photonics West and Demonstrated in Leti’s Booth February 2nd, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project